Table 1. Baseline characteristics of kidney transplant recipients at registration.
| Variable | Value | |
|---|---|---|
| Recipient age | 45.4±12.7 | |
| Recipient, male, n (%) | 377 (59.3) | |
| Deceased donor, n (%) | 252 (39.6) | |
| Retransplantation, n (%) | 45 (7.1) | |
| Dialysis modality, preemptive: HD: PD | 106: 442: 124 | |
| Duration of dialysis, months | 36.0 (6.0–71.0) | |
| Causes of ESRD, n (%) | ||
| Glomerulonephritis | 226 (35.5) | |
| Unknown | 149 (23.4) | |
| Diabetes mellitus | 112 (17.6) | |
| Hypertension | 87 (13.7) | |
| Polycystic kidney disease | 37 (5.8) | |
| Lupus nephritis | 8 (1.3) | |
| Reflux nephropathy | 4 (0.6) | |
| Others | 13 (2.0) | |
| Total HLA mismatch number | 3.3±1.6 | |
| Panel reactive antibody, n (%) | ||
| Class I > 50% | 49 (7.7) | |
| Class II > 50% | 30 (4.7) | |
| Cross matching test positivity, n (%) | ||
| T-cell | 6 (0.9) | |
| B-cell | 18 (2.8) | |
| ABO incompatibility | 85 (13.4) | |
Continuous variables with normal distributions are presented with mean±S.D, whereas continuous variables with non-normal distributions are presented with median (interquartile range)
Abbreviations: HD, hemodialysis; PD, peritoneal dialysis; ESRD, end stage renal disease; HLA, human leukocyte antigen